Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 37 filings·Updated 2 Oct 2026
Showing 10 of 37 filings.
2 Oct 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisement - Special Window for Transfer and Dematerialization of Physical Securities.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 23:46View Source
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Abbott India Limited: Trading Window closed from October 1, 2026 and shall reopen after 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ending on September 30, 2026.

Abbott India Limited: Trading Window closed from October 1, 2026 and shall reopen after 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ending on September 30, 2026.

Filed 10:35View Source
7 Sept 20261 filing
Company UpdateResignation of Company Secretary / Compliance Officer

Resignation of Company Secretary and Compliance Officer of the Company.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 20:06View Source
14 Aug 20262 filings
AGM/EGMAGM

Abbott India’s 82nd AGM held via VC/OAVM on Aug 13, 2026; all resolutions approved

AGM details

  • AGM held on August 13, 2026 via VC/OAVM.
  • Notice for 82nd AGM dated May 11, 2026.

Resolutions and outcomes

  • All resolutions put to vote were approved by the requisite majority.
  • Consolidated Scrutinizer's Report on voting issued.
Filed 18:19View Source
Company UpdateNewspaper Publication

Newspaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 18:03View Source
13 Aug 20261 filing
AGM/EGMAGM

Abbott India holds 82nd AGM via VC; approves dividends, director changes, and cost auditor remuneration.

AGM Details

  • 82nd AGM held August 13, 2026, at 10:00 am, via VC/OAVM; concluded 12:45 pm.
  • Meeting conducted through video-conferencing; remote e-voting facility provided; 94 members attended.

Key Resolutions

  • Ordinary: Adopt Audited financial statements for year ended March 31, 2026.
  • Ordinary: Declare final dividend of Rs 525 and special dividend of Rs 131 per share.
  • Ordinary: Retirement by rotation of Munir Shaikh; not offered for re-appointment.
  • Ordinary: Kaiyomarz Marfatia to be re-appointed as Director.
  • Special: Ratify remuneration payable to Kishore Bhatia & Associates for 2026-27.

Voting Results

  • Voting results to be declared within 48 hours; resolutions, if passed, take effect August 13, 2026.

Dividend

  • Dividend: Proposed final Rs 525 and special Rs 131 per share.

Director Changes

  • Sudarshan Jain appointed Chairman of the Board effective August 13, 2026.
  • Munir Shaikh retires by rotation; not re-appointed.
  • Kaiyomarz Marfatia to be re-appointed as Director.

Auditor Appointments

  • Remuneration for Kishore Bhatia & Associates Cost Auditors ratified for 2026-27.

Material Related Party Transactions

  • No material related party transactions were approved.

Other Material Approvals

  • No other material approvals disclosed.
Filed 17:18View Source
12 Aug 20262 filings
ResultFinancial Results

Abbott India approves unaudited results for quarter ended 30 June 2026; limited review finds no misstatement

Unaudited results (Q1 Jun 2026)

  • Board approves unaudited results for quarter ended 30 June 2026.
  • Walker Chandiok & Co LLP issued limited review report; no material misstatement identified.
Filed 19:18View Source
Board MeetingOutcome of Board Meeting

Abbott India approves Q1 2026 unaudited results; appoints Sudarshan Jain as Chairman

Financial results

  • Unaudited Q1 2026 results approved; Limited Review Report by Walker Chandiok & Co LLP.

Chairman transition

  • Munir Shaikh stepped down as Chairman; Sudarshan Jain appointed Chairman, effective August 13, 2026.

Auditor remarks

  • Walker Chandiok & Co LLP reviewed results; no material misstatement identified; audit opinion not expressed.
Filed 18:45View Source
4 Aug 20261 filing
Board Meeting

Abbott India Board to consider unaudited June quarter results on Aug 12, 2026

Meeting Details

  • Board meeting scheduled for August 12, 2026; time and venue not disclosed.

Key Agenda Items

  • Consider and approve unaudited financial results for quarter ended June 30, 2026.

Other Notes

  • Trading window closed from July 1, 2026 to August 14, 2026 (inclusive).
Filed 16:57View Source
20 Jul 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisement for Eighty-second Annual General Meeting, E-voting facility and Dividend.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 16:34View Source
Showing 10 of 37 filings